ArticleCell death & disease2024

PQR309, a dual PI3K/mTOR inhibitor, synergizes with gemcitabine by impairing the GSK-3β and STAT3/HSP60 signaling pathways to treat nasopharyngeal carcinoma.

Jiaxin Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.